Rørvik J, Haukaas S
Departments of Radiology, University Hospital of Bergen, Bergen, Norway.
Curr Opin Urol. 2001 Mar;11(2):181-8. doi: 10.1097/00042307-200103000-00009.
Magnetic resonance imaging has been shown to be more accurate than other imaging modalities in the evaluation of both malignancies and various benign lesions of the prostate. Despite its superiority, because of its cost and low availability, magnetic resonance imaging should play a role as a problem-solver secondary to computed tomography or ultrasonography. The routine use of magnetic resonance imaging in the staging of prostate cancer before surgery cannot be justified on the basis of published data. Magnetic resonance imaging has been proved to be of value in the planning and delivery of different types of radiotherapy to patients with prostate cancer. Through the use of combined magnetic resonance imaging and the new modality, magnetic resonance spectroscopy, the accuracy and specificity of tumour detection and the delineation of tumour extent can be improved. Magnetic resonance technology is rapidly evolving, and in the near future, new possibilities such as biological imaging will have a great impact on magnetic resonance imaging of the prostate.
在评估前列腺恶性肿瘤和各种良性病变方面，磁共振成像已被证明比其他成像方式更准确。尽管其具有优越性，但由于成本高且可用性低，磁共振成像应作为计算机断层扫描或超声检查后的问题解决手段发挥作用。根据已发表的数据，术前在前列腺癌分期中常规使用磁共振成像尚无充分理由。事实证明，磁共振成像在为前列腺癌患者制定和实施不同类型的放射治疗方面具有价值。通过结合使用磁共振成像和新的模式——磁共振波谱，可以提高肿瘤检测的准确性和特异性以及肿瘤范围的界定。磁共振技术正在迅速发展，在不久的将来，诸如生物成像等新可能性将对前列腺的磁共振成像产生重大影响。
